John Bradshaw

John Bradshaw

Director/Board Member at SYNAIRGEN PLC

Net worth: 266 141 $ as of 2026-06-29

62 year
Health Technology
Commercial Services
Finance

Profile

John Bradshaw is the founder of Crescendo Biologics Ltd., founded in 2007.
Mr. Bradshaw is also the founder of Eight19 Ltd...
Mr. Bradshaw is an Independent Non-Executive Director at Creo Medical Ltd. since 2013.
Mr. Bradshaw is a Director at Autifony SRL.
Mr. Bradshaw is a Director at Syncona Management LLP.
Mr. Bradshaw is a Director at Syncona Discovery Ltd. since 2017.
Mr. Bradshaw is an Independent Non-Executive Director at Synairgen Plc starting 2025.
Mr. Bradshaw is Co-Chief Financial Officer at Avillion LLP since 2014.
Mr. Bradshaw is an Advisor at Science Creates Ventures LLP.
Mr. Bradshaw was Senior Independent Non-Executive Director at Creo Medical Group Plc.
Mr. Bradshaw was Independent Non-Executive Director at Ixico Plc from 2013 to 2022.
Mr. Bradshaw was Chief Financial Officer & Director at TheraCryf Plc.
Mr. Bradshaw was Finance Director at Analysys Ltd. Mr. Bradshaw was Director at PneumaCare Ltd. Mr. Bradshaw was Director at TheraCryf Pharma Ltd. from 2015 to 2017.
Mr. Bradshaw was Chief Financial Officer & Director at TopiVert Ltd. Mr. Bradshaw was Director at Burrowmoor Consulting Ltd. from 2006 to 2012.
Mr. Bradshaw was Finance Director at Healthcare Executive Group.
Mr. Bradshaw was Chief Financial Officer at Gyrus Group Ltd. from 1997 to 2008.
Mr. Bradshaw was Chief Financial Officer at TeraView Ltd. Mr. Bradshaw was Chief Financial Officer at Plastic Logic, Inc. from 2006 to 2008.
Mr. Bradshaw was Principal at Arthur Andersen (UK) from 1986 to 1997.
Mr. Bradshaw was Chief Financial Officer at Nxera Pharma UK Ltd. from 2008 to 2015.
Mr. Bradshaw was Chief Financial Officer at GlySure Ltd. Mr. Bradshaw was Chief Financial Officer at Syncona Partners LLP.
Mr. Bradshaw was Partner at Bradshaw Daniel Ltd. from 2012 to 2020.
Mr. Bradshaw was Chief Financial Officer at Syncona Investment Management Ltd. from 2016 to 2021.
Mr. Bradshaw completed undergraduate studies at The University of Liverpool in 1986.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-12-30 1,371,082 ( 0.31% ) 266 141 $ 2026-06-29

John Bradshaw active positions

CompaniesPositionStart
SYNAIRGEN PLC Director/Board Member 2025-04-30
Consultant / Advisor -
Director/Board Member 2017-01-16
Syncona Management LLP
Director/Board Member -
Director/Board Member -
Director of Finance/CFO -
Director/Board Member -

Former positions of John Bradshaw

CompaniesPositionEnd
CREO MEDICAL GROUP PLC Director/Board Member 2025-05-21
IXICO PLC Director/Board Member 2022-04-29
░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
See the detail of John Bradshaw's experience

Training of John Bradshaw

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

28

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies28

Health Technology

Commercial Services

Health Services

Health Technology

Consumer Services

Electronic Technology

Commercial Services

Technology Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Electronic Technology

Health Services

Utilities

Health Technology

Electronic Technology

Health Technology

Finance

Burrowmoor Consulting Ltd.

Health Technology

Commercial Services

Technology Services

Syncona Management LLP

Health Technology

Finance

Finance

Finance